SELENOI

selenoprotein I, the group of Selenoproteins

Basic information

Region (hg38): 2:26308547-26395885

Previous symbols: [ "EPT1" ]

Links

ENSG00000138018NCBI:85465OMIM:607915HGNC:29361Uniprot:Q9C0D9AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Spastic paraplegia 81, autosomal recessiveARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingCraniofacial; Neurologic; Ophthalmologic28052917; 29500230

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SELENOI gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SELENOI gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
3
clinvar
7
missense
16
clinvar
1
clinvar
17
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
9
clinvar
9
Total 0 0 16 4 13

Variants in SELENOI

This is a list of pathogenic ClinVar variants found in the SELENOI region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-26309979-G-A not specified Uncertain significance (Sep 11, 2024)3498191
2-26310050-A-G not specified Uncertain significance (Sep 26, 2023)3085586
2-26310074-C-T not specified Likely benign (Jun 24, 2022)2296824
2-26310084-G-A not specified Uncertain significance (Aug 19, 2024)3498094
2-26310090-G-A not specified Uncertain significance (Dec 08, 2021)2395146
2-26310718-T-C not specified Uncertain significance (Apr 04, 2024)3271348
2-26310730-C-G not specified Uncertain significance (Sep 16, 2022)2311939
2-26310732-G-A not specified Uncertain significance (Oct 04, 2024)3498165
2-26310817-C-T not specified Uncertain significance (Nov 06, 2023)3085572
2-26310844-C-T not specified Uncertain significance (Dec 09, 2024)3498200
2-26310850-G-C not specified Uncertain significance (Oct 31, 2023)3085564
2-26310889-C-T not specified Uncertain significance (Apr 18, 2024)3271386
2-26310913-C-T not specified Uncertain significance (Oct 10, 2023)3085560
2-26310937-C-G not specified Uncertain significance (Jul 13, 2022)2253697
2-26310988-C-T not specified Uncertain significance (Dec 27, 2023)3085555
2-26311018-G-C not specified Uncertain significance (Dec 15, 2022)2361575
2-26311030-C-T Likely benign (Apr 01, 2023)2650742
2-26311086-C-T not specified Uncertain significance (Mar 01, 2024)2387187
2-26311117-G-A not specified Uncertain significance (Feb 07, 2023)2468069
2-26311194-G-T not specified Uncertain significance (Aug 26, 2024)2384447
2-26311219-G-A Benign (Sep 01, 2022)2650743
2-26311224-C-T not specified Uncertain significance (Aug 19, 2024)3498196
2-26311233-A-T not specified Uncertain significance (Oct 21, 2024)3498120
2-26311258-T-C not specified Uncertain significance (Aug 01, 2024)3498103
2-26311287-T-A not specified Uncertain significance (Sep 04, 2024)3498157

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SELENOIprotein_codingprotein_codingENST00000260585 1087345
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.6420.358124629081246370.0000321
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.671311970.6650.000009382556
Missense in Polyphen3679.30.453971079
Synonymous-0.09817775.91.010.00000389768
Loss of Function3.41420.80.1939.68e-7259

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001840.000184
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004690.0000464
European (Non-Finnish)0.00001830.0000177
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes phosphatidylethanolamine biosynthesis from CDP-ethanolamine. It thereby plays a central role in the formation and maintenance of vesicular membranes. Involved in the formation of phosphatidylethanolamine via 'Kennedy' pathway.;
Pathway
Ether lipid metabolism - Homo sapiens (human);Glycerophospholipid metabolism - Homo sapiens (human);Phosphonate and phosphinate metabolism - Homo sapiens (human);Selenium Micronutrient Network;Selenium Metabolism and Selenoproteins;Metabolism of lipids;Metabolism;Synthesis of PE;phosphatidylethanolamine biosynthesis II;Glycerophospholipid biosynthesis;Phospholipid metabolism (Consensus)

Intolerance Scores

loftool
rvis_EVS
-0.21
rvis_percentile_EVS
38.58

Haploinsufficiency Scores

pHI
hipred
Y
hipred_score
0.786
ghis
0.578

Essentials

essential_gene_CRISPR
essential_gene_CRISPR2
essential_gene_gene_trap
K
gene_indispensability_pred
gene_indispensability_score

Mouse Genome Informatics

Gene name
Selenoi
Phenotype

Gene ontology

Biological process
phosphatidylethanolamine biosynthetic process
Cellular component
endoplasmic reticulum membrane;Golgi apparatus;integral component of membrane
Molecular function
ethanolaminephosphotransferase activity;phosphotransferase activity, for other substituted phosphate groups;metal ion binding